These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23086383)

  • 21. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple oral Candida infections in patients with Sjogren's syndrome -- prevalence and clinical and drug susceptibility profiles.
    Yan Z; Young AL; Hua H; Xu Y
    J Rheumatol; 2011 Nov; 38(11):2428-31. PubMed ID: 21844143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluconazole susceptibility of Candida isolates from oropharyngeal candidosis.
    Dannaoui E; Lacoste V; Prat C; Piens MA
    Mycoses; 1997 Nov; 40(7-8):279-82. PubMed ID: 9476510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.
    Sojakova M; Liptajova D; Borovsky M; Subik J
    Mycopathologia; 2004 Feb; 157(2):163-9. PubMed ID: 15119851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM; Reviákina V; Dolande M; Selgrad S
    Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and laboratorial features of oral candidiasis in HIV-positive patients.
    Spalanzani RN; Mattos K; Marques LI; Barros PFD; Pereira PIP; Paniago AMM; Mendes RP; Chang MR
    Rev Soc Bras Med Trop; 2018; 51(3):352-356. PubMed ID: 29972567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
    Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
    Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities.
    Le Guennec R; Reynes J; Mallié M; Pujol C; Janbon F; Bastide JM
    J Clin Microbiol; 1995 Oct; 33(10):2732-7. PubMed ID: 8567915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and Antifungal Activity Profile of Candida Species Isolated from Patients with Pemphigus Vulgaris with Oral Lesions.
    Pakshir K; Ghasemi N; Zomorodian K; Jowkar F; Nouraei H; Dastgheib L
    Acta Dermatovenerol Croat; 2019 Sep; 27(3):137-141. PubMed ID: 31542055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis.
    Hamza OJ; Matee MI; Moshi MJ; Simon EN; Mugusi F; Mikx FH; Helderman WH; Rijs AJ; van der Ven AJ; Verweij PE
    BMC Microbiol; 2008 Aug; 8():135. PubMed ID: 18694525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.
    Martín-Mazuelos E; Gutiérrez MJ; Aller AI; Bernal S; Martínez MA; Montero O; Quindós G
    J Antimicrob Chemother; 1999 Apr; 43(4):477-81. PubMed ID: 10350375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predisposing factors for oropharyngeal colonization of yeasts in human immunodeficiency virus-infected patients: a prospective cross-sectional study.
    Lin JN; Lin CC; Lai CH; Yang YL; Chen HT; Weng HC; Hsieh LY; Kuo YC; Lauderdale TL; Tseng FC; Lin HH; Lo HJ
    J Microbiol Immunol Infect; 2013 Apr; 46(2):129-35. PubMed ID: 22921200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal susceptibility of oral isolates of Candida species from chronic kidney disease patients on chronic dialysis.
    de la Rosa-García E; Olalde-Hernández MJ; Irigoyen-Camacho ME; Mondragón-Padilla A; Mendoza-Juache A; Sánchez-Vargas LO
    J Mycol Med; 2020 Sep; 30(3):101009. PubMed ID: 32620497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
    Colombo AL; Nakagawa Z; Valdetaro F; Branchini ML; Kussano EJ; Nucci M
    Med Mycol; 2003 Jun; 41(3):235-9. PubMed ID: 12964715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral candidiasis in liver transplant patients: species identification and antifungal susceptibility profile.
    Sabadin CES; Matta DAD; Hoppe L; Fernandes FAV; Melo ASA; Rigo L; Barbosa DA
    Einstein (Sao Paulo); 2024; 22():eAO0138. PubMed ID: 38775603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral Candida colonization in HIV-infected patients in Londrina-PR, Brazil: antifungal susceptibility and virulence factors.
    Paula SB; Morey AT; Santos JP; Santos PM; Gameiro DG; Kerbauy G; Sena EM; Ueda LT; Carneiro M; Pinge-Filho P; Yamauchi LM; Yamada-Ogatta SF
    J Infect Dev Ctries; 2015 Dec; 9(12):1350-9. PubMed ID: 26719941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.